Stonnington Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$1.26M Sell
16,770
-1,043
-6% -$87.5K 0.33% 79
2022
Q4
$1.61M Sell
17,813
-3,127
-15% -$302K 0.45% 65
2022
Q3
$1.92M Sell
20,940
-1,527
-7% -$151K 0.54% 52
2022
Q2
$2.11M Sell
22,467
-5,412
-19% -$528K 0.56% 49
2022
Q1
$2.91M Sell
27,879
-3,828
-12% -$402K 0.7% 41
2021
Q4
$3.36M Buy
31,707
+17,982
+131% +$1.66M 0.72% 40
2021
Q3
$1.16M Sell
13,725
-1,210
-8% -$101K 0.26% 96
2021
Q2
$1.2M Sell
14,935
-765
-5% -$62.6K 0.27% 100
2021
Q1
$1.31M Buy
+15,700
New +$1.14M 0.32% 88

Other funds holding CVS

Stonnington Group's CVS Position: Q1 2023 in Review

Stonnington Group reduced its CVS Health (CVS) stake by 5.9% in Q1 2023, selling an estimated $87.5K and leaving 16,770 shares worth $1.26M. The position accounts for 0.33% of the portfolio, ranked #79.

Stonnington Group first reported a position in CVS in Q1 2021 and has held it in 9 quarters since. The position peaked at $3.36M in Q4 2021. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • Stonnington Group held 16,770 shares of CVS Health worth $1.26M as of Q1 2023.
  • Stonnington Group sold 1,043 CVS Health shares in Q1 2023, an estimated $87.5K.
  • CVS Health made up 0.33% of Stonnington Group's portfolio in Q1 2023, its #79 holding.
  • Stonnington Group first reported a position in CVS Health in Q1 2021 and has held it in 9 quarters since.
  • Stonnington Group's CVS Health position peaked at $3.36M in Q4 2021.
  • 2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Stonnington Group's 13F filing for Q1 2023, filed 14 Apr 2023.